Results 121 to 130 of about 741,475 (253)
International Journal of Cancer, Volume 159, Issue 12, Page 2861-2869, 15 December 2026.ABSTRACT Sub‐Saharan Africa (SSA) faces a unique cancer burden, characterized by a disproportionately high mortality‐to‐incidence ratio, a large share of infection‐related cancers, and distinct environmental exposures. Implementation of national policies on primary prevention is limited, and public literacy regarding cancer risk and curability remains ...
Anthony Kityo +14 more
wiley +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 12, Page 11394-11406, December 2026.ABSTRACT Aims This study quantified the real‐world healthcare costs and utilisation associated with diagnosed metabolic dysfunction‐associated steatotic liver disease (MASLD) among adults with Type 2 diabetes (T2D). Methods We conducted a retrospective cohort study using IQVIA PharMetrics Plus Closed Health Plan data from January 2016 to June 2025 ...
Tien Hoang Tran +3 more
wiley +1 more source
Hepatitis B vaccination in the Columbian Amazon : effectiveness and factors influencing vaccine coverage [PDF]
A vaccination coverage survey was carried out in the Colombian Amazon, a former high endemic area for hepatitis B, involving 3573 children less than II years old. It was carried out in Leticia, Puerto Narifio, and Araracuara, both urban and rural areas.
De La Hoz, Fernando
core +1 more source
Chronic Hepatitis B in the United States: Current Landscape, Unmet Needs and Future Directions
Journal of Viral Hepatitis, Volume 33, Issue 12, December 2026.ABSTRACT Chronic hepatitis B (CHB) infection represents a major public health challenge in the US, with substantial unmet needs related to timely diagnosis, treatment, monitoring and disease management. This narrative review explores the CHB landscape in the US, including gaps in patient care, the evolving therapeutic landscape, the clinical utility of
Chari Cohen +3 more
wiley +1 more source
Virological techniques for the diagnosis and monitoring of hepatitis B and C
Annals of Hepatology, 2009 Stéphane Chevaliez +1 more
doaj +1 more source
Counselling services for persons with Hepatitis C
, 2007 Consultative Council on Hepatitis C ...
Consultative Council on Hepatitis C
core
New therapeutic options for metabolic‐associated steatotic liver disease
British Journal of Clinical Pharmacology, Volume 92, Issue 11, Page 3770-3777, November 2026.An increasing number of patients are being diagnosed with metabolic dysfunction‐associated steatotic liver disease (MASLD). MASLD results from disturbances in hepatic lipid metabolism and is associated with an increased risk of cirrhosis and hepatocellular carcinoma and significant extrahepatic morbidity, including cardiovascular disease and ...
Tessa Straatmijer, Midas Mulder
wiley +1 more source
Virus‐Induced Genome Editing in the Parasitic Plant Phtheirospermum japonicum
Plant, Cell &Environment, EarlyView.
Hannes Ruwe +3 more
wiley +1 more source
Neoadjuvant Therapy for Non‐Small Cell Lung Cancer: Recent Advances and Future Directions
Cancer Medicine, Volume 15, Issue 11, November 2026.ABSTRACT Neoadjuvant therapy has become an integral component of the multidisciplinary management of resectable non–small cell lung cancer (NSCLC). The introduction of immune checkpoint inhibitors (ICIs) has transformed the perioperative treatment landscape by improving pathological response rates, reducing the risk of recurrence, and offering the ...
Hao An +15 more
wiley +1 more source